Comprehensive Psychiatry
Volume 46, Issue 3 , Pages 159-166 , May 2005

Family history validation of a definition of mixed depression

  • Franco Benazzi

      Affiliations

    • Corresponding Author Information48010 Castiglione di Cervia, RA, Italy. Tel.: +39 335 6191 852; fax: +39 054 330 069.

References 

  1. Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: E. & S. Livingstone; 1921;
  2. Koukopoulos A. Ewald Hecker's description of cyclothymia as a cyclical mood disorder: its relevance to the modern concept of bipolar II. J. Affect. Disord. 2003;73:199–205
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.. Washington (DC): American Psychiatric Association; 2000;
  4. McElroy SL, Keck PE, Pope HG, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am. J. Psychiatry. 1992;149:1633–1644
  5. Freeman MP, McElroy SL. Clinical picture and etiologic models of mixed states. In:  Akiskal HS editors. Bipolarity: beyond classic mania. Psychiatr. Clin. North Am. vol. 22:1999;p. 535–546
  6. Koukopoulos A, Koukopoulos A. Agitated depression as a mixed state and the problem of melancholia. In:  Akiskal HS editors. Bipolarity: beyond classic mania. Psychiatr. Clin. North Am. vol. 22:1999;p. 547–564
  7. Perugi G, Akiskal HS, Micheli C, Musetti L, Paiano A, Quilici C, et al. Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J. Affect. Disord. 1997;43:169–180
  8. Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J. Affect. Disord. 2001;67:105–114
  9. Maj M, Pirozzi R, Magliano L, Bartoli L. Agitated depression in bipolar I disorder: prevalence, phenomenology and outcome. Am. J. Psychiatry. 2003;160:2134–2140
  10. Sato T, Bottlender R, Schroter A, Moller H-J. Frequency of manic symptoms during a depressive episode and unipolar ‘depressive mixed state’ as bipolar spectrum. Acta Psychiatr. Scand. 2003;107:268–274
  11. Akiskal HS, Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J. Affect. Disord. 2003;73:113–122
  12. Benazzi F, Akiskal HS. Clinical and factor analytic-validation of depressive mixed states: a report from the Ravenna-San Diego collaboration. Curr. Opin. Psychiatry. 2003;16(Suppl. 2):S71–S78
  13. Benazzi F. Bipolar II disorder and major depressive disorder: continuity or discontinuity?. World J. Biol. Psychiatry. 2003;4:166–171
  14. Benazzi F. Depression with racing thoughts. Psychiatry Res. 2003;120:273–282
  15. Benazzi F. Clinical and family history markers of bipolar II disorder. Can. J. Psychiatry. 2003;48:208–209
  16. Benazzi F. Depressive mixed state: dimensional versus categorical definitions. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:129–134
  17. Benazzi F. Bipolar II depressive mixed state: finding a useful definition. Compr. Psychiatry. 2003;44:21–27
  18. Benazzi F, Helmi S, Bland L. Agitated depression: unipolar? Bipolar? Or both?. Ann. Clin. Psychiatry. 2002;14:97–104
  19. Benazzi F. Which could be a clinically useful definition of depressive mixed state?. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002;26:1105–1111
  20. Benazzi F. Depressive mixed state frequency: age/gender effects. Psychiatry Clin. Neurosci. 2002;56:537–543
  21. Benazzi F. Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder. Compr. Psychiatry. 2001;42:461–465
  22. Benazzi F. Age at onset of bipolar II depressive mixed state. Psychiatry Res. 2001;103:229–235
  23. Akiskal HS, Benazzi F. Bipolar II and major depressive disorder: categorical distinction or continuum? J Affect Disord [in press].
  24. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psychiatry. 2003;160:4–12
  25. Akiskal HS. Classification, diagnosis and boundaries of bipolar disorders: a review. In:  Maj M,  Akiskal HS,  Lopez-Ibor JJ,  Sartorius N editor. Bipolar disorder. Chichester (UK): Wiley; 2002;p. 1–52
  26. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990;
  27. Winokur G, Tsuang MT. The natural history of mania, depression, and schizophrenia. Washington (DC): American Psychiatric Press; 1996;
  28. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Disord. 2002;4(Suppl. 1):11–14
  29. Coryell W. Bipolar II disorder: the importance of hypomania. In:  Goldberg JF,  Harrow M editor. Bipolar disorders. Clinical course and outcome. Washington (DC): American Psychiatric Press; 1999;p. 219–236
  30. Goodwin DW, Guze SB. Psychiatric diagnosis. New York: Oxford University Press; 1996;
  31. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry. 1970;126:983–987
  32. Kendler KS. Toward a scientific psychiatric nosology. Strengths and limitations. Arch. Gen. Psychiatry. 1990;47:969–973
  33. Ghaemi SN, Ko JY, Goodwin FK. “Cade's disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can. J. Psychiatry. 2002;47:125–134
  34. Leonhard K. The classification of endogenous psychoses. New York: Irvington; 1979;
  35. Angst J. The etiology and nosology of endogenous depressive psychoses. Foreign Psychiatry. 1973;2:1–108
  36. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr. Scand. 1966;194(Suppl):9–17
  37. Winokur G, Clayton P, Reich T. Manic-depressive illness. St. Louis: Mosby; 1969;
  38. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch. Gen. Psychiatry. 1976;33:1062–1066
  39. Akiskal HS, Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol. Bull. 1987;23:68–73
  40. Benazzi F. How to treat bipolar II depression and bipolar II mixed depression?. Int. J. Neuropsychopharmacol. 2004;105–106
  41. Bottlender R, Sato T, Kleindienst N, Strausz A, Moller H-J. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J. Affect. Disord. 2004;78:149–152
  42. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J. Affect. Disord. 2003;73:133–146
  43. Hantouche EG, Akiskal HS, Lencrenon S, Allilaire J-F, Sechter D, Azorin J-M, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J. Affect. Disord. 1998;50:163–173
  44. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J. Affect. Disord. 1997;43:163–166
  45. Benazzi F. Frequency of bipolar spectrum in 111 private practice depression outpatients. Eur. Arch. Psychiatry. Clin. Neurosci. 2003;253:203–208
  46. Manning JS, Haykal RF, Akiskal HS. The role of bipolarity in depression in the family practice setting. In:  Akiskal HS editors. Bipolarity: beyond classic mania. Psychiatr. Clin. North. Am. vol. 22:1999;p. 689–703
  47. Dunner DL, Tay KL. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr. Psychiatry. 1993;34:303–307
  48. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H-J, Hirschfeld R. Re-evaluating the prevalence and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 2000;59(Suppl. 1):S5–S30
  49. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr. Psychiatry. 1998;39:63–71
  50. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am. J. Psychiatry. 2001;158:1265–1270
  51. Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord [in press].
  52. Benazzi F, Akiskal HS. Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J. Affect. Disord. 2003;73:33–38
  53. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J. Clin. Psychopharmacol. 1996;16(Suppl. 1):4S–14S
  54. Benazzi F. Borderline personality disorder and bipolar II disorder in private practice depressed outpatients. Compr. Psychiatry. 2000;41:106–110
  55. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders—Clinician Version (SCID-CV). Washington (DC): American Psychiatric Press; 1997;
  56. Williams JBW, Terman M, Link MJ, Amira L, Rosenthal NE. Hypomania Interview Guide (including hyperthymia). Current assessment version (HIGH-C). Norwood (NJ): Clinical Assessment Tools Packet, Center for Environmental Therapeutics; 1994;
  57. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M. Brief screening for family psychiatric history. The family history screen. Arch. Gen. Psychiatry. 2000;57:675–682
  58. Simpson SG, McMahon FJ, McInnis MG, MacKinnon DF, Edwin D, Folstein SE, et al. Diagnostic reliability of bipolar II diagnosis. Arch. Gen. Psychiatry. 2002;59:736–740
  59. Benazzi F. Diagnosis of bipolar II disorder: a comparison of structured versus semistructured interviews. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:985–991
  60. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the schedules for clinical assessment in neuropsychiatry (SCAN). Psychol. Med. 2001;31:1001–1013
  61. Akiskal HS, Hantouche EG, Bourgeois ML, Azorin JM, Sechter D, Allilaire JF, et al. Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J. Affect. Disord. 2001;67:89–96
  62. Benazzi F, Akiskal HS. The dual factor structure of self-rated MDQ hypomania: energized-activity versus irritable-thought racing. J. Affect. Disord. 2003;73:59–64
  63. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 2000;
  64. Sato T, Bottlender R, Kleindienst N, Moller H-J. Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am. J. Psychiatry. 2002;159:968–974
  65. Swann AC, Janicak PL, Calabrese JR, Bowden CL, Dilsaver SC, Morris DD, et al. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J. Affect. Disord. 2001;67:123–132
  66. Perugi G, Maremmani I, Toni C, Madaro D, Mata B, Akiskal HS. The contrasting influence of depressive and hyperthymic temperaments on psychometrically derived manic subtypes. Psychiatry Res. 2001;101:249–258
  67. Bauer MS, Crits-Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch. Gen. Psychiatry. 1991;48:807–812
  68. Cassidy F, Forest K, Murry E, Carroll BJ. A factor analysis of the signs and symptoms of mania. Arch. Gen. Psychiatry. 1998;55:27–32
  69. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J. Affect. Disord. 2003;73:39–47
  70. Benazzi F. Factor structure of recalled DSM-IV hypomanic symptoms of bipolar-II disorder. Compr Psychiatry [in press].
  71. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed.. Philadelphia: Lippincott Williams & Wilkins; 1998;
  72. Hadjipavlou G, Mok H, Yathan LN. Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord. 2004;6:14–25
  73. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 2003;5:456–463
  74. Amsterdam JD, Shults J, Brunswink DJ, Hundert M. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression—low manic switch rate. Bipolar Disord. 2004;6:75–81
  75. Delini-Stula A, Mikkelsen H, Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression—a meta-analysis of moclobemide studies. J. Affect. Disord. 1995;35:21–30
  76. Filteau MJ, Baruch P, Lapierre YD, Bakish D, Blanchard A. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients. Int. Clin. Psychopharmacol. 1995;10:51–54
  77. Beasley CM, Sayler ME, Bosomworth JC, Wernicke JF. High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression. J. Clin. Psychopharmacol. 1991;11:166–174
  78. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. Depression and anxiety. In:  Hardman JG,  Limbird LE,  Goodman Gilman A editor. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed.. New York: McGraw-Hill; 2001;p. 447–483
  79. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry. 1995;152:1130–1138
  80. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421–433
  81. Ghaemi SN, Rosenquist KL, Ko JY, Baldassano CF, Kontos NJ, Ross J, et al. Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry. 2004;161:163–165
  82. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am. J. Psychiatry. 2001;158:1265–1270
  83. Benazzi F. Relapse prevention and antidepressants. Lancet. 2003;361:2158

PII: S0010-440X(04)00123-3

doi: 10.1016/j.comppsych.2004.07.034

Comprehensive Psychiatry
Volume 46, Issue 3 , Pages 159-166 , May 2005